HLNE
Hamilton Lane Incorporated
HLNE has the edge over HOOD overall, supported by stronger fundamentals and lower modeled downside.
HOOD
Robinhood Markets, Inc.
HOOD offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
HLNE Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
HLNE's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like HLNE.
HOOD Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
HOOD's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like HOOD.
HLNE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $93.88 | — |
| Current | 14x | $93.88 | — |
| Cheap | 17x | $116 | +24% |
| Fair | 27x | $179 | +91% |
| Expensive | 37x | $249 | +165% |
Historical ranges are pointers, not guarantees.
HLNE has the edge over HOOD in the historical PE scenario, which offers more potential upside but is not a forecast.
HOOD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 30x | $81.35 | — |
| Cheap | 37x | $78.84 | -3.1% |
| Current | 38x | $81.35 | — |
| Fair | 51x | $110 | +35% |
| Expensive | 74x | $160 | +96% |
Historical ranges are pointers, not guarantees.
HOOD's PE is in its cheap range at 38x. If earnings grow as analysts expect, today's price would be 30x next year's earnings.
HLNE Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for HLNE, with profitability improving.
HOOD Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect strong earnings and revenue growth for HOOD, with profitability improving. However, they disagree widely on these estimates.
HLNE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.30 | +8.4% |
| Q3 2026 | $6.74 | +22% |
| Q2 2026 | $6.56 | +26% |
| Q1 2026 | $5.91 | +9.6% |
| Q4 2025 | $5.57 | +1.6% |
| Q4 2021 | $4.59 | +89% |
| Q3 2021 | $4.15 | +115% |
| Q2 2021 | $3.40 | +86% |
| Q1 2021 | $2.73 | +28% |
HLNE has the edge over HOOD on earnings, with more consistent year-over-year improvement.
HOOD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.72 | +26% |
| Q3 2026 | $2.16 | -10% |
| Q2 2026 | $2.26 | +15% |
| Q1 2026 | $2.06 | +18% |
| Q4 2025 | $2.05 | +31% |
| Q3 2025 | $2.40 | +314% |
| Q2 2025 | $1.96 | +513% |
| Q1 2025 | $1.75 | +1150% |
| Q4 2024 | $1.56 | +$2.17 |
HOOD earned $2.16 per share over the past year, down 10% from the year before.
HLNE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $204.4M | +7.1% |
| Q2 2026 | $275.3M | +56% |
| Q1 2026 | $193.6M | -2.2% |
| Q4 2025 | $198.6M | +18% |
| Q3 2025 | $190.9M | +27% |
| Q2 2025 | $176M | -11% |
| Q1 2025 | $198M | +18% |
| Q2 2024 | $196.7M | +57% |
HLNE's revenue is growing: $204M last quarter, up 7.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 87% | +46 points |
| Q2 2026 | 46% | +2.2 points |
| Q1 2026 | 42% | 0 points |
| Q4 2025 | 43% | -1.7 points |
| Q3 2025 | 42% | -3 points |
| Q2 2025 | 44% | -1.8 points |
| Q1 2025 | 42% | -2.5 points |
| Q4 2024 | 45% | N/A |
HLNE has the edge over HOOD on profitability, with a higher operating margin.
HOOD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.4B | +12% |
| Q2 2026 | $1.3B | +32% |
| Q1 2026 | $1.1B | +15% |
| Q4 2025 | $1.3B | +27% |
| Q3 2025 | $1.3B | +100% |
| Q2 2025 | $989M | +45% |
| Q1 2025 | $927M | +50% |
| Q4 2024 | $1B | +115% |
HOOD has the edge over HLNE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 44% | -5.9 points |
| Q2 2026 | 54% | +9.5 points |
| Q1 2026 | 39% | -1.5 points |
| Q4 2025 | 52% | -3.5 points |
| Q3 2025 | 50% | +26 points |
| Q2 2025 | 45% | +17 points |
| Q1 2025 | 40% | +14 points |
| Q4 2024 | 55% | +49 points |
HOOD's operating margin was 44% last quarter, down 5.9 points from the same quarter a year ago.
HLNE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $22.8M | -81% |
| Q2 2026 | $98.9M | -22% |
| Q1 2026 | $101.2M | +182% |
| Q4 2025 | $72.4M | +23% |
| Q3 2025 | $120.1M | +3.7% |
| Q2 2025 | $127.6M | +63% |
| Q1 2025 | $35.8M | +78% |
| Q2 2024 | $78.2M | 0% |
HLNE has the edge over HOOD on cash flow, with more consistent year-over-year improvement.
HOOD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.2B | +$2.8B |
| Q2 2026 | $720M | -79% |
| Q1 2026 | $2B | +217% |
| Q4 2025 | -$937M | +$463M |
| Q3 2025 | -$1.6B | -187% |
| Q2 2025 | $3.5B | +6398% |
| Q1 2025 | $642M | +$1.3B |
| Q4 2024 | -$1.4B | -246% |
HOOD's free cash flow was $3B over the past year, up 159% from the year before. Free cash flow isn't a meaningful measure for financial services companies like HOOD.
HLNE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.5% | +1.3M shares |
| 1 year | +2.3% | +1.3M shares |
| 3 years | +3.8% | +2M shares |
| 5 years | +60% | +21M shares |
| Available history | +88% | +26.1M shares |
HLNE has 56M diluted shares, up 2.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $50.6M |
| Q1 2026 | $23.2M |
| Q4 2025 | $595,000 |
| Q3 2025 | $835,000 |
| Q2 2025 | $7,000 |
| Q1 2025 | $252.9M |
| Q4 2024 | $72,000 |
| Q3 2024 | $391,000 |
HOOD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -1M shares |
| 1 year | -0.8% | -6.9M shares |
| 3 years | +1.8% | +15.9M shares |
| 5 years | +292% | +679M shares |
| Available history | +7.2% | +60.8M shares |
HOOD has the edge over HLNE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $25M |
| Q2 2026 | $414M |
| Q1 2026 | $250M |
| Q4 2025 | $100M |
| Q3 2025 | $107M |
| Q2 2025 | $124M |
| Q1 2025 | $322M |
| Q4 2024 | $160M |
HOOD spent $789M buying back its own shares over the past year, up 11% from the year before.
HLNE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | 0.0x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 0.1x | Very low |
| Q1 2025 | 0.2x | Very low |
| Q4 2024 | 0.1x | Very low |
HLNE has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like HLNE.
HOOD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.3x | Net Cash |
| Q2 2026 | -2.1x | Net Cash |
| Q1 2026 | -2.2x | Net Cash |
| Q4 2025 | -1.9x | Net Cash |
| Q3 2025 | -2.1x | Net Cash |
| Q2 2025 | -2.6x | Net Cash |
| Q1 2025 | -3.3x | Net Cash |
| Q4 2024 | -3.8x | Net Cash |
HOOD has the edge over HLNE on leverage, with a lower net debt burden relative to earnings.
HLNE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 31.1 | Neutral |
HLNE's weekly RSI is 51 (neutral) and its Stochastic is 31 (neutral).
HOOD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.8 | Neutral |
| Stochastic | 9.5 | Oversold |
HOOD's weekly RSI is 41 (neutral) and its Stochastic is 10 (oversold).
HLNE PE vs Financial Services Sector
| Metric | HLNE | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 7% above |
| PE % | 4 | 63 | 59 pts below |
HLNE has the edge over HOOD on valuation relative to its sector.
HOOD PE vs Financial Services Sector
| Metric | HOOD | Sector median | Relative |
|---|---|---|---|
| PE | 38x | 13x | 189% above |
| PE % | 22 | 66 | 44 pts below |
HOOD is trading at 38x earnings, a 189% premium to the Financial Services sector's median of 13x.
HLNE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $86.3 | 8.8% above |
| 20 week MA | $90.6 | 3.6% above |
| 50 week MA | $101.7 | 7.7% below |
| 100 week MA | $123.8 | 24% below |
| 200 week MA | $117.2 | 20% below |
HLNE has the edge over HOOD on trend strength, trading above more of its moving averages.
HOOD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $97.8 | 17% below |
| 20 week MA | $102.2 | 20% below |
| 50 week MA | $95.4 | 15% below |
| 100 week MA | $88.5 | 8.1% below |
| 200 week MA | $52.1 | 56% above |
HOOD has fallen below most of its moving averages, though it's still 56% above its 200-week average.
HLNE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $61.2 | $78.7 | +29% |
| 2021 | $78.7 | $103.7 | +32% |
| 2022 | $103.7 | $65.5 | -37% |
| 2023 | $65.5 | $113.4 | +73% |
| 2024 | $113.4 | $151.6 | +34% |
| 2025 | $151.6 | $138.5 | -8.6% |
| 2026 YTD | $138.5 | $93.9 | -32% |
HLNE is down 32% so far in 2026, after finishing higher in four of the previous six years.
HOOD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $35.2 | $18.9 | -46% |
| 2022 | $18.9 | $7.95 | -58% |
| 2023 | $7.95 | $12.7 | +60% |
| 2024 | $12.7 | $39.0 | +206% |
| 2025 | $39.0 | $118.1 | +203% |
| 2026 YTD | $118.1 | $81.4 | -31% |
HOOD has the edge over HLNE on returns for 2026, with the stronger performance.